MGH
Boston, MA
Marianne Kearney Chase is currently the Senior Director of Clinical Trial Operations for the Neurological Clinical Research Institute (NCRI) and Healey Center for ALS at MGH. The Healey Center, along with key collaborators, designed and initiated the first Platform Trial for Amyotrophic Lateral Sclerosis, which launched in 2020. The NCRI is the Clinical Coordinating Center for the National Institute of Neurological Diseases and Stroke (NINDS) Network for Excellence in Neuroscience Clinical Trials (NeuroNEXT); the Clinical and Data Coordinating Center for the Northeast Amyotrophic Lateral Sclerosis (NEALS) Network and the Parkinson’s Study Group (PSG) Network. Marianne is an active member of the Clinical Trial Transformation Initiative (CTTI) and has over 25 years’ experience in both investigator-initiated NIH / foundation funded and industry sponsored research including Pre-Clinical Study Design, Clinical Study Coordination, Clinical Site Management, Protocol Development, Regulatory Compliance and Project Management. In addition, serves as an adjunct faculty member for the NINDS funded Clinical Trials Methodology Course and has developed and presented courses on various topics including; Good Clinical Practice, Good Source Documentation and Data Management Practices, Adverse Event Reporting, Standard Operating Procedures (SOPs), Overall Management of Multi-Center Clinical Trials, and Complexity of Clinical Trial Design: Ethical and Practical Challenges.
Disclosure information not submitted.
F07 - Ethical Issues in Complex Trial Design
Friday, November 19, 2021
1:30 PM – 2:30 PM ET